retatrutide fda approval status 2024 produces up to 30.3% weight loss in Phase 3 trial ⚠️ BEWARE OF RETATRUTIDE SOLD

The mindless calories, the second helping you did not need, the late-night grazing, are exactly the calories that turn a clean surplus into a fat-gaining one

It is not on the Australian Register of Therapeutic Goods

While most people tolerate them well, its helpful to know what side effects to expect, especially in the first few weeks of treatment: nausea vomiting diarrhea constipation headaches fatigue These symptoms are well-documented across clinical trials and often appear during the dose escalation phase

Covers Wegovy (oral $149/mo via Walgreens, injection $349/mo direct), Saxenda (limited), Ozempic and Rybelsus (savings card $25/mo for eligible commercial)

J Biol Chem 259(3):183441 Xie S, Zhang M, Shi W, Xing Y, Huang Y, Fang WX, Liu SQ, Chen MY, Zhang T, Chen S, Zeng X, Wang S, Deng W, Tang Q (2022) Long-term activation of glucagon-like peptide-1 receptor by dulaglutide prevents diabetic heart failure and metabolic remodeling in type 2 diabetes

Ready to Optimize Your Weight Loss Journey